Thomas Francis Moore

1 Patent

• US121955472025

  Dosing for Combination Treatment with Anti-cd20/anti-cd3 Bispecific Antibody and Anti-cd79b Antibody Drug Conjugate

  Hoffmann-la Roche Inc.

  0 cites